Abstract Summary
Children and adults with cerebral palsy develop impairments termed contractures that dramatically reduce their function, making activity and participation in the society difficult. An improved understanding of the muscle specific causes for contracture development are needed to develop targeted therapeutic interventions. Here we show using a transgenic mouse model, that loss of muscle stem cells can lead to contractures and may represent a therapeutic target in humans